NO990909D0 - Pharmaceutical surface composition containing lornoxicam and a disodium salt of EDTA - Google Patents

Pharmaceutical surface composition containing lornoxicam and a disodium salt of EDTA

Info

Publication number
NO990909D0
NO990909D0 NO990909A NO990909A NO990909D0 NO 990909 D0 NO990909 D0 NO 990909D0 NO 990909 A NO990909 A NO 990909A NO 990909 A NO990909 A NO 990909A NO 990909 D0 NO990909 D0 NO 990909D0
Authority
NO
Norway
Prior art keywords
edta
composition containing
disodium salt
surface composition
lornoxicam
Prior art date
Application number
NO990909A
Other languages
Norwegian (no)
Other versions
NO326350B1 (en
NO990909L (en
Inventor
Hermann Ruckendorfer
Philippus Egger
Original Assignee
Nycomed Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria Gmbh filed Critical Nycomed Austria Gmbh
Publication of NO990909L publication Critical patent/NO990909L/en
Publication of NO990909D0 publication Critical patent/NO990909D0/en
Publication of NO326350B1 publication Critical patent/NO326350B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition is disclosed which contains lornoxicam and a disodic salt of EDTA.
NO19990909A 1996-09-03 1999-02-25 Pharmaceutical composition containing lornoxicam and a disodium salt of EDTA NO326350B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0156496A ATA156496A (en) 1996-09-03 1996-09-03 PHARMACEUTICAL COMPOSITION
PCT/EP1997/004742 WO1998009654A1 (en) 1996-09-03 1997-09-01 Pharmaceutical composition containing lornoxicam and a disodic salt of edta

Publications (3)

Publication Number Publication Date
NO990909L NO990909L (en) 1999-02-25
NO990909D0 true NO990909D0 (en) 1999-02-25
NO326350B1 NO326350B1 (en) 2008-11-17

Family

ID=3516134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990909A NO326350B1 (en) 1996-09-03 1999-02-25 Pharmaceutical composition containing lornoxicam and a disodium salt of EDTA

Country Status (12)

Country Link
EP (1) EP0934079B1 (en)
JP (1) JP4122062B2 (en)
CN (1) CN1108822C (en)
AT (2) ATA156496A (en)
AU (1) AU4552597A (en)
CA (1) CA2264626C (en)
DE (1) DE59706450D1 (en)
DK (1) DK0934079T3 (en)
ES (1) ES2172002T3 (en)
NO (1) NO326350B1 (en)
PT (1) PT934079E (en)
WO (1) WO1998009654A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172183A (en) * 1999-12-21 2001-06-26 Wakamoto Pharmaceut Co Ltd Ophthalmic pharmaceutical composition
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (en) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions
DE10161077A1 (en) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
CN102647971B (en) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 For comprising the container of the compositions of meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012127496A1 (en) 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
CN106727364B (en) * 2016-12-02 2020-01-24 苏州天马医药集团天吉生物制药有限公司 Freeze-drying process of lornoxicam for injection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203703B (en) * 1983-05-23 1989-02-15 Bruschettin Srl Storage stable antiinflammatory eye drops
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
WO1996041646A2 (en) * 1995-06-13 1996-12-27 Dyer, Alison, Margaret Pharmaceutical compositions containing lornoxicam and cyclodextrin

Also Published As

Publication number Publication date
NO326350B1 (en) 2008-11-17
NO990909L (en) 1999-02-25
PT934079E (en) 2002-06-28
EP0934079B1 (en) 2002-02-20
CA2264626A1 (en) 1998-03-12
CA2264626C (en) 2009-03-24
ATE213420T1 (en) 2002-03-15
JP4122062B2 (en) 2008-07-23
ES2172002T3 (en) 2002-09-16
AU4552597A (en) 1998-03-26
CN1228710A (en) 1999-09-15
CN1108822C (en) 2003-05-21
DE59706450D1 (en) 2002-03-28
EP0934079A1 (en) 1999-08-11
DK0934079T3 (en) 2002-04-02
WO1998009654A1 (en) 1998-03-12
JP2000517331A (en) 2000-12-26
ATA156496A (en) 1997-10-15

Similar Documents

Publication Publication Date Title
EE9800187A (en) Prodrugs of thrombin inhibitors
LV12102A (en) Inhibitors of rotamase functions
PT1093815E (en) ORAL FORMULATION OF 2-METHYL-THENE-BENZODIAZEPINE
DK0850004T3 (en) Toothbrush and method of making one
PL322904A1 (en) Sulphonamidic inhibitors of aspartil protease containing oxidated heterocyclic group
NO974495L (en) Compound and compositions for delivery of active agents
PL322877A1 (en) Sulphonamidic inhibitors of aspartil hiv protease containing thf
NO954056L (en) Combination of laser tracker and camera based coordinate measurement
NO990909D0 (en) Pharmaceutical surface composition containing lornoxicam and a disodium salt of EDTA
MX9205725A (en) GENERATING FORMULATIONS OF NON-AZIDIC GAS
DK42093D0 (en) METHOD OF ADMINISTRATION
DK516487D0 (en) PHARMACEUTICAL CONTAINING A COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM ANTAGONISTS
DE69325599D1 (en) Encryption of digital speech using an encryption memory
IS1821B (en) Composition of a 5-HT uptake inhibitor and an optional 5-HT 1A antagonist
HUP9904065A2 (en) Coated particle formulations containing olanzapine
KR970000228A (en) Oral preparations of S-etodolak
BR9407743A (en) Oral composition of calcium peroxide-bicarbonate
FR2686425B1 (en) SEISMIC SOURCE OF WELL.
NO924528L (en) DERIVATIVES OF HUMAN BALL-SALT-STIMULATED LIPASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE
FI973500A (en) Derivatives of 3-pyrrolidylidene-2-one cephalosporins
NO982888L (en) Compositions and Methods for the Treatment of Underground Formations
KR970000226A (en) Oral Formulations of S-Ibuprofen
GR1001368B (en) Pharmaceutical agents.
KR950003706U (en) Primary supply of brick and block loader
KR970027978U (en) Structure of slide hammer

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA PHARMA A/S, DK

MK1K Patent expired